Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
Journal of the American College of Cardiology|December 29, 2000
Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study GroupJ N Nanas, G Alexopoulos, M I Anastasiou-Nana, et al.Cell Death and Differentiation|October 17, 2018
Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanomaJan Rožanc, Theodore Sakellaropoulos, Asier Antoranz, et al.Osteoarthritis and Cartilage|January 25, 2014
Modeling of signaling pathways in chondrocytes based on phosphoproteomic and cytokine release dataI N Melas, A D Chairakaki, E I Chatzopoulou, et al.Cancers|August 12, 2023
Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel TherapeuticsAnthi Kolokotroni, Evi Gkikopoulou, Vagelis Rinotas, et al.Kidney International Reports|February 12, 2020
A Functional Landscape of CKD Entities From Public Transcriptomic DataFerenc Tajti, Christoph Kuppe, Asier Antoranz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.International Journal of Molecular Sciences|January 15, 2021
Multiscale Regulation of the Intervertebral Disc: Achievements in Experimental, In Silico, and Regenerative ResearchLaura Baumgartner, Karin Wuertz-Kozak, Christine L Le Maitre, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.British Journal of Cancer|October 12, 2000
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancerJ P Sculier, J J Lafitte, M Paesmans, et al.Current Vascular Pharmacology|November 1, 2021
Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery DiseaseNikoleta Karampetsou, Aspasia Tzani, Ilias P Doulamis, et al.Pageof 16